I am the Founder, President, & CEO of OncoSynergy a biopharmaceutical spinout of UCSF based in San Francisco.
I am a brain surgery dropout... I left clinical neurosurgery training in order to start OncoSynergy so that I could focus all of my efforts into advancing medicine and improving outcomes for cancer patients.
Shockingly, neuroscience was not an available major at the University of Washington in the early 90s so I received my BS in Psychology instead. I then pursued the dual MD/PhD at the University of Virginia through the Medical Scientist Training Program (MSTP) where I was Dean's Merit Scholar. I received my PhD in Neuroscience and, still hungry for more, deferred neurosurgery residency for 3 years to study brain tumors at Oxford University as a Nicolas Kurti Junior Fellow. After a brief stint as a neurosurgery resident at the "hospital to the stars" (Cedars-Sinai) I moved to San Francisco in 2010 to pursue my vision for OncoSynergy. To pay the bills in the meantime, I was also a Postdoctoral Scholar at UCSF in the Brain Tumor Research Center.
I am interested in cancer biology with a particular focus on tumors of the CNS such as glioblastoma for which my company has been granted Orphan Drug Designation by the FDA.